Greger Lindberg
Overview
Explore the profile of Greger Lindberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
2360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vujasinovic M, Omae M, Panic N, Fjellgren E, Bloch N, Kikec Z, et al.
Eur J Gastroenterol Hepatol
. 2025 Feb;
PMID: 39976001
Objective: Long-distance running has become increasingly popular in recent decades all over the world. Besides musculoskeletal injuries, gastrointestinal (GI) complaints are also very common in athletes. Methods: A systematic search...
2.
Jansson-Rehnberg A, Drewes A, Sponheim J, Borgfelt C, Munch A, Graf W, et al.
Scand J Gastroenterol
. 2024 Feb;
59(5):543-546.
PMID: 38343268
The basic principle for the treatment of idiopathic diarrhoea (functional diarrhoea K59.1) is to delay transit through the gut in order to promote the absorption of electrolytes and water. Under...
3.
Lindberg G, Mohammadian G
Front Med (Lausanne)
. 2023 Jul;
10:1141035.
PMID: 37484861
Two thirds of the patients we believed to have IBS in the 1970's have since been possible to diagnose with treatable conditions like bile acid diarrhea, inflammatory bowel disease, microscopic...
4.
Jansson-Rehnberg A, Borgfeldt C, Munch A, Graf W, Simren M, Lindberg G, et al.
Lakartidningen
. 2023 Mar;
120.
PMID: 36994929
The basic principle for treatment of idiopathic diarrhea is to delay transit through the gut in order to promote absorption of electrolytes and water. Under mild conditions bulking agents may...
5.
Tejera V, Ohman L, Aabakken L, Fellstrom B, Hausken T, Hovde O, et al.
Aliment Pharmacol Ther
. 2022 Aug;
56(6):968-979.
PMID: 35942522
Background: Low-grade immune activation in the gut is a potential treatment target in irritable bowel syndrome (IBS). Aims: To determine improvement in IBS symptoms after mesalazine treatment, and the utility...
6.
Hedstrom A, Kvarnstrom M, Lindberg G, Alsabeah S, Alsabeah H, Ndegwa N, et al.
Scand J Gastroenterol
. 2022 Apr;
57(10):1250-1256.
PMID: 35465817
Introduction: Pancreatic exocrine insufficiency (PEI) results in maldigestion of fat, leading to steatorrhea, malabsorption and weight loss. Sjögren's syndrome (SS) is a chronic autoimmune rheumatic disease with unknown etiology. The...
7.
Agreus L, Borgquist L, Tsoposidis A, Wallenius V, Kostic S, Lundell L, et al.
Lakartidningen
. 2021 Jul;
118.
PMID: 34216475
PPIs (Proton-pump inhibitors) offers the best treatment for acid related diseases. The predominant indications for PPI prescription are: GERD eradication of H. pylori-infection in combination with antibiotics H. pylori-negative peptic...
8.
Moll J, Myers P, Zhang C, Eriksen C, Wolf J, Appelberg K, et al.
Gastroenterology
. 2021 Mar;
160(7):2423-2434.e5.
PMID: 33662387
Background & Aims: IgA exerts its primary function at mucosal surfaces, where it binds microbial antigens to regulate bacterial growth and epithelial attachment. One third of individuals with IgA deficiency...
9.
Mohammadian G, Dlugosz A, Shetye J, Lindberg G
Scand J Gastroenterol
. 2020 May;
55(5):543-548.
PMID: 32442056
Enteroendocrine cells (EEC) have been suggested to have a role in the pathogenesis of irritable bowel syndrome (IBS). Although many studies have analysed possible numeric changes of EEC in IBS,...
10.
Lindberg G
Best Pract Res Clin Gastroenterol
. 2019 Oct;
40-41:101635.
PMID: 31594655
New diagnostic techniques have advanced our knowledge about the irritable bowel syndrome. The majority of patients that we believed to have a psychosomatic disorder have received other diagnoses explaining their...